207 results on '"Fijuth J"'
Search Results
2. Clinical and Radiomics-Based Deep Learning Predictive Model for Early Treatment Failure after Neoadjuvant Radiochemotherapy for Rectal Cancer
3. Phase I Study of Novel Radioenhancer NBTXR3 Activated by Radiotherapy in Cisplatin-Ineligible Locally Advanced HNSCC Patients
4. Discriminatory power of MRI for differentiation of adrenal non-adenomas vs adenomas evaluated by means of ROC analysis: Can biopsy be obviated?
5. Serum Micrornas As Biomarkers Of HPV-Associated Oropharyngeal Cancer
6. OC-0323: Serum microRNAs as xerostomia biomarkers in oropharyngeal cancer patients undergoing radiotherapy
7. Phase IIa/IIb clinical trial of NC-6004 (Nanoparticle Cisplatin) plus Pembrolizumab in patients with head and neck cancer (HNSCC) who have failed platinum or a platinum-containing regimen
8. Magnetic resonance imaging differentiation of adrenal masses at 1.5 t: t2-weighted images, chemical shift imaging, and gd-dtpa dynamic studies
9. Effective treatment of recalcitrant Hailey-Hailey disease with electron beam radiotherapy
10. Radiation Oncology Training in Poland: Multi-Institutional Survey
11. NBTXR3 for the Treatment of Elderly Frail Patients with Locally Advanced HNSCC
12. FT3-L Dynamics in Blood Could be Predictive of Time of Occurrence Lymphocyte Nadir in Patients Undergoing Preoperative Chemoradiotherapy for Rectal Cancer.
13. Left Anterior Descending Coronary Artery Dose-Sparing Effects of Volumetric Modulated Arc Therapy in Patients Ineligible for Deep-Inspiration Breath-Hold in Left Breast Radiation Therapy
14. EP-2294: Serum miRNA-based model predicts xerostomia in patients treated for head and neck cancer
15. PO-0744: LBP is predictive for long-term cardiac complications in breast cancer patients
16. Dose escalation using 3-dimensional conformal radiotherapy in management of non-small cell lung cancer; preliminary results on 22 patients
17. 132 Poster - Phase IIa/IIb clinical trial of NC-6004 (Nanoparticle Cisplatin) plus Pembrolizumab in patients with head and neck cancer (HNSCC) who have failed platinum or a platinum-containing regimen
18. Clinical and Molecular Risk Factors for Glioblastoma Multiforme in the Era of New WHO CNS Tumors Classification
19. Scintigraphic Evaluation of Salivary Function after Intensity Modulated Radiotherapy for Head and Neck Cancer
20. MiR-215 as a Biomarker of Radiation-Induced Cardiac Toxicity
21. Quality of Life in Patients With Localized Prostate Cancer: High-Dose Rate Brachytherapy Versus Laparoscopic Prostatectomy
22. Feasibility of Texture Analysis–Based Dosimetry in Computed Tomography Scans During Radiation Therapy of Non-Small Cell Lung Cancer
23. PO-0735: Prognostic value of microRNA-205 in endometrial cancer patients treated with adjuvant radiotherapy
24. EP-1855: Computed Tomography lung texture changes due to radiotherapy for non-small cell lung cancer
25. EP-1166 Lipopolysacharide-binding protein in biodosimetry during radiotherapy for lung cancer
26. Characterization of a new polymer gel for radiosurgery dosimetry using magnetic resonance imaging
27. OC-0573: Availability and outcomes of radiotherapy in central Poland
28. OC-0365: Salvage high dose rate brachytherapy in radio-recurrent prostate cancer- analysis of 106 patients
29. 7023 POSTER On Board Imaging Shifts in Prostate Cancer Patients Treated Using External Beam Radiation Therapy
30. Post-operative radiochemotherapy in patients with gastric cancer: one department’s experience of 56 patients
31. Persistent Improvement of Previously Recalcitrant Hailey-Hailey Disease with Electron Beam Radiotherapy
32. Characterization of a new polymer gel for radiosurgery dosimetry using Magnetic Resonance Imaging
33. 6/Porównanie wczesnych odczynów popromiennych wg skali RTOG w radioterapii raka gruczołu krokowego u chorych leczonych metodą IMRT oraz 3D CRT
34. 131. Brachyterapia i teleterapia raka gruczołu krokowego – możliwości i ograniczenia
35. 135. Results of whole brain radiotherapy for patients with brain metastases from lung cancer: assessment of the RPA classification value
36. 69. Znaczenie prognostyczne objętości guza i węzłów chłonnych w porównaniu do zaawansowania TNM w radioterapii chorych na niedrobnokomórkowego raka płuca (NRP)
37. 14. Search for improvement of the therapeutic ratio in radiotherapy for non-small cell lung cancer (NSCLC)
38. 63. Stereotactic radiotherapy for primary and recurrent brain tumors. A new method for improvement of the treatment results?
39. 57. Physical and dosimetric aspects of quality assurance in stereotactic radiotherapy
40. 40. Comparison of two accelerated radiotherapy regimens in management of locally advanced non-small cell lung cancer (NSCLC) – hyper-fractionated conventional accelerated radiotherapy (RAHIP) and accelerated conformal radiotherapy with concurrent boost (RT-BOOST)
41. 29. Results of postoperative radiotherapy in Low-Grade Gliomas
42. 13 Zastosowanie brachyterapii HDR w leczeniu chorych na miejscowo zaawansowanego raka przełyku
43. Dose escalation using 3-dimensional conformal radiotherapy in management of non-small cell lung cancer; preliminary results on 22 patients
44. 23 Wynik leczenia skojarzonego chorych na ziarnicę złośliwą wg protokołu AMA + RT
45. 8 Ocena wyników leczenia samodzielną radioterapią chorych na ziarnicę złośliwą w stopniach klinicznego zaawansowania I-IIIA leczonych w latach 1978–1993
46. 76 Aspekty techniczne i dozymetryczne w stereotaktycznej radioterapii guzów OUN
47. 68P Ocena tolerancji konformalnej radioterapii z zastostosowaniem dawek całkowitych powyżej 70 Gy u chorych na niedrobnokomórkowego raka płuca. Doniesienie wstępne
48. 404 Interstitial brachytherapy for oral cavity carcinoma: Search of the factors responsible for late complications
49. Prostate-specific antigen decline: a major prognostic factor for prostate cancer treated with radiation therapy.
50. Results of radiotherapy in combined treatment of pituitary adenumas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.